I am a clinical investigator at the Institute for Drug Development (IDD) at Cancer Therapy and Research Center of University of Texas Health Science Center at San Antonio. I have finished my Fellowship in Medical Oncology and ‘Advanced fellowship in Drug Development Research’ from the IDD. IDD is known for being the largest Oncology drug development research program in the United States and has set unprecedented standards for the development of novel anti-cancer agents, playing a key role in the preclinical and clinical development of 20 new cancer drugs that were subsequently approved by the Food and Drug Administration (FDA). I have been working at IDD since 2006 and have worked as clinical investigator on about 22 investigational clinical studies on novel anti-cancer drugs; additionally I have been a sub-investigator on 80 other clinical studies. Besides the clinical responsibilities in medical oncology and Internal Medicine my research focus is on translational research of novel anti-cancer agents and on studying the pre-clinical and clinical aspect of these agents.